Core Viewpoint - Shanghai Xuantai Pharmaceutical Technology Co., Ltd. announced a cash dividend distribution of CNY 0.037 per share for the fiscal year 2024, approved at the annual shareholders' meeting on May 29, 2025 [2][4]. Summary by Sections Dividend Distribution Plan - The dividend distribution is based on the total share capital of 453,340,000 shares, excluding 4,336,109 shares held in the company's repurchase account, resulting in a base of 449,003,891 shares for the distribution [4]. - The total cash dividend to be distributed amounts to CNY 16,613,143.97 [4]. Dividend Payment Details - The cash dividend of CNY 0.037 per share is inclusive of tax [4]. - The distribution will be made to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [3][4]. Tax Implications - For individual shareholders holding unrestricted shares for over one year, the dividend income is exempt from personal income tax, resulting in a net cash dividend of CNY 0.037 per share [11]. - For shares held for less than one year, the tax treatment varies, with a 20% tax rate applicable for holdings of one month or less [11]. - Non-resident enterprises will be subject to a 10% withholding tax, leading to a net cash dividend of CNY 0.0333 per share [13]. Implementation Method - The dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation, with specific arrangements for shareholders who have not designated a trading account [8][10].
上海宣泰医药科技股份有限公司2024年年度权益分派实施公告